Chemoinformaics analysis of mallotophilippen A
| Molecular Weight | 498.572 | nRot | 7 |
| Heavy Atom Molecular Weight | 464.3 | nRig | 19 |
| Exact Molecular Weight | 498.225 | nRing | 3 |
| Solubility: LogS | -3.751 | nHRing | 1 |
| Solubility: LogP | 6.25 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 75.847 |
| nHD | 5 | BPOL | 37.581 |
| QED | 0.321 |
| Synth | 3.96 |
| Natural Product Likeliness | 2.136 |
| NR-PPAR-gamma | 0.412 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.655 |
| Pgp-sub | 0.004 |
| HIA | 0.458 |
| CACO-2 | -5.277 |
| MDCK | 0.0000189 |
| BBB | 0.002 |
| PPB | 1.02305 |
| VDSS | 0.261 |
| FU | 0.00767967 |
| CYP1A2-inh | 0.177 |
| CYP1A2-sub | 0.883 |
| CYP2c19-inh | 0.115 |
| CYP2c19-sub | 0.177 |
| CYP2c9-inh | 0.698 |
| CYP2c9-sub | 0.753 |
| CYP2d6-inh | 0.277 |
| CYP2d6-sub | 0.167 |
| CYP3a4-inh | 0.193 |
| CYP3a4-sub | 0.395 |
| CL | 1.651 |
| T12 | 0.083 |
| hERG | 0.005 |
| Ames | 0.035 |
| ROA | 0.048 |
| SkinSen | 0.954 |
| Carcinogencity | 0.119 |
| EI | 0.817 |
| Respiratory | 0.175 |
| NR-Aromatase | 0.923 |
| Antiviral | Yes |
| Prediction | 0.878136 |